Viking Therapeutics (VKTX) Misses Q1 EPS by 1c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook